| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.003 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.085 | 0.003 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |